2011;364:1920-1931.) In the present study, selenium supplementation enhanced the effect of
antithyroid drugs in patients with recurrent Graves' disease.
[2.] Haggerty JJ Jr, Evans DL, Golden RN, Pedersen CA, Simon JS, Nemeroff CB.The presence of
antithyroid antibodies in patients with affective and nonaffective psychiatric disorders.
This can be a potentially life-threatening medical condition, and immediate treatment with
antithyroid medication is necessary to lower thyroid hormone levels.
Of 67 patients with GD, 85.1% had been treated with thionamide
antithyroid drugs, mostly with methimazole, others 9.0% underwent replacement therapy, and 5.9% underwent thyroidectomy.
Conversely, some cardiovascular complications have been confirmed to persist in overt hyperthyroid patients in spite of active
antithyroid treatment [3,10].
We examined the effects of 2-mercapto-1-methylimidazole (methimazole) and 6-propyl-2-thiouracil (PTU), which are agents that inhibit all peroxidases and are widely used as
antithyroid agents targeting thyroid peroxidase.
Antithyroid antibodies and parity: further evidence for microchimerism in autoimmune thyroid disease.
Among deficient subjects,
antithyroid peroxidase levels were significantly higher than levels measured in the sufficient group.
However, the main focus is to describe the use of
antithyroid medications in the treatment of hyperthyroidism and nursing considerations in the care of patients taking these medications.
New European guidelines call for erythrocyte sedimentation rate/C-reactive protein and blood differential testing for chronic spontaneous urticaria, but others--like liver function tests, hepatitis B, antinuclear antibody, stool, urinalysis, thyroid function, and
antithyroid antibodies --should be directed by the history.
Definitive therapy may include
antithyroid medication, radioactive iodine ablation (RIA), and/or thyroidectomy.
Effects of l-thyroxine administration, TSH-receptor antibodies and smoking on the risk of recurrence in Graves' hyperthyroidism treated with
antithyroid drugs: a double-blind prospective randomized study.
